Expert Review Of Hematology
- 期刊全稱:Expert Review Of Hematology
- 簡稱:EXPERT REV HEMATOL
- ISSN:1747-4086
- ESSN:1747-4086
- 研究方向:HEMATOLOGY
投稿咨詢
免費咨詢
2023最新分區
Expert Review Of Hematology英文簡介
Advanced molecular research techniques have transformed hematology in recent years. With improved understanding of hematologic diseases, we now have the opportunity to research and evaluate new biological therapies, new drugs and drug combinations, new treatment schedules and novel approaches including stem cell transplantation. We can also expect proteomics, molecular genetics and biomarker research to facilitate new diagnostic approaches and the identification of appropriate therapies. Further advances in our knowledge regarding the formation and function of blood cells and blood-forming tissues should ensue, and it will be a major challenge for hematologists to adopt these new paradigms and develop integrated strategies to define the best possible patient care. Expert Review of Hematology (1747-4086) puts these advances in context and explores how they will translate directly into clinical practice.
Expert Review Of Hematology中文簡介
《Expert Review Of Hematology》是一本由TAYLOR & FRANCIS LTD出版商出版的專業醫學期刊,該刊創刊于2008年,刊期6 issues/year,該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中,該刊分區信息為大類學科:醫學 4區,小類學科:血液學 4區;在JCR(Journal Citation Reports)分區等級為Q3。該刊發文范圍涵蓋血液學等領域,旨在及時、準確、全面地報道國內外血液學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等,促進學術交流,鼓勵學術創新。2021年影響因子為2.819,平均審稿速度較慢,6-12周。
中科院分區最新升級版(當前數據版本:2021年12月最新升級版)
大類學科 |
分區 |
小類學科 |
分區 |
Top期刊 |
綜述期刊 |
醫學 |
4區 |
HEMATOLOGY
血液學
|
4區
|
否 |
是 |
JCR分區(當前數據版本:2021-2022年最新版)
JCR分區等級 |
JCR所屬學科 |
分區 |
影響因子 |
Q3 |
HEMATOLOGY |
Q3 |
2.819 |
期刊指數
影響因子 |
h-index |
Gold OA文章占比 |
研究類文章占比 |
OA開放訪問 |
平均審稿速度 |
2.819 |
31 |
9.42% |
7.53% |
未開放 |
較慢,6-12周 |
IF值(影響因子)趨勢圖